169 related articles for article (PubMed ID: 22648866)
1. Trypanosomal Trans-sialidases: Valuable Synthetic Tools and Targets for Medicinal Chemistry.
Meinke S; Thiem J
Top Curr Chem; 2015; 367():231-50. PubMed ID: 22648866
[TBL] [Abstract][Full Text] [Related]
2. Sialic acid C-glycosides with aromatic residues: investigating enzyme binding and inhibition of Trypanosoma cruzi trans-sialidase.
Meinke S; Schroven A; Thiem J
Org Biomol Chem; 2011 Jun; 9(12):4487-97. PubMed ID: 21528140
[TBL] [Abstract][Full Text] [Related]
3. Donor substrate binding to trans-sialidase of Trypanosoma cruzi as studied by STD NMR.
Blume A; Neubacher B; Thiem J; Peters T
Carbohydr Res; 2007 Sep; 342(12-13):1904-9. PubMed ID: 17597593
[TBL] [Abstract][Full Text] [Related]
4. Trans-sialidase and mucins of Trypanosoma cruzi: an important interplay for the parasite.
Giorgi ME; de Lederkremer RM
Carbohydr Res; 2011 Sep; 346(12):1389-93. PubMed ID: 21645882
[TBL] [Abstract][Full Text] [Related]
5. Continuous nonradioactive method for screening trypanosomal trans-sialidase activity and its inhibitors.
Sartor PA; Agusti R; Leguizamón MS; Campetella O; de Lederkremer RM
Glycobiology; 2010 Aug; 20(8):982-90. PubMed ID: 20375068
[TBL] [Abstract][Full Text] [Related]
6. Discovery of novel inhibitors of Trypanosoma cruzi trans-sialidase from in silico screening.
Neres J; Brewer ML; Ratier L; Botti H; Buschiazzo A; Edwards PN; Mortenson PN; Charlton MH; Alzari PM; Frasch AC; Bryce RA; Douglas KT
Bioorg Med Chem Lett; 2009 Feb; 19(3):589-96. PubMed ID: 19144516
[TBL] [Abstract][Full Text] [Related]
7. Comparative rates of sialylation by recombinant trans-sialidase and inhibitor properties of synthetic oligosaccharides from Trypanosoma cruzi mucins-containing galactofuranose and galactopyranose.
Agustí R; Giorgi ME; Mendoza VM; Gallo-Rodriguez C; de Lederkremer RM
Bioorg Med Chem; 2007 Apr; 15(7):2611-6. PubMed ID: 17292612
[TBL] [Abstract][Full Text] [Related]
8. The chemistry and biology of trypanosomal trans-sialidases: virulence factors in Chagas disease and sleeping sickness.
Schauer R; Kamerling JP
Chembiochem; 2011 Oct; 12(15):2246-64. PubMed ID: 21956798
[TBL] [Abstract][Full Text] [Related]
9. Preparation of sialylated oligosaccharides employing recombinant trans-sialidase from Trypanosoma cruzi.
Neubacher B; Schmidt D; Ziegelmuller P; Thiem J
Org Biomol Chem; 2005 Apr; 3(8):1551-6. PubMed ID: 15827656
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and the effect of 1,2,3-triazole sialylmimetic neoglycoconjugates on Trypanosoma cruzi and its cell surface trans-sialidase.
Campo VL; Sesti-Costa R; Carneiro ZA; Silva JS; Schenkman S; Carvalho I
Bioorg Med Chem; 2012 Jan; 20(1):145-56. PubMed ID: 22154559
[TBL] [Abstract][Full Text] [Related]
11. Enzymatic Decoration of Prebiotic Galacto-oligosaccharides (Vivinal GOS) with Sialic Acid Using Trypanosoma cruzi trans-Sialidase and Two Bovine Sialoglycoconjugates as Donor Substrates.
Wilbrink MH; ten Kate GA; Sanders P; Gerwig GJ; van Leeuwen SS; Sallomons E; Klarenbeek B; Hage JA; van Vuure CA; Dijkhuizen L; Kamerling JP
J Agric Food Chem; 2015 Jul; 63(25):5976-84. PubMed ID: 26044147
[TBL] [Abstract][Full Text] [Related]
12. alpha-2,3-sialyllactitol is a donor substrate for Trypanosoma cruzi trans-sialidase.
Previato JO
Glycobiology; 2004 Oct; 14(10):25G; author reply 26G. PubMed ID: 15382323
[No Abstract] [Full Text] [Related]
13. Transfer of modified sialic acids by Trypanosoma cruzi trans-sialidase for attachment of functional groups to oligosaccharide.
Lee KB; Lee YC
Anal Biochem; 1994 Feb; 216(2):358-64. PubMed ID: 8179190
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and enzymatic evaluation of 3-O-substituted aryl β-D-galactopyranosides as inhibitors of Trypanosoma cruzi trans-sialidase.
Silva BL; S Filho JD; Andrade P; Carvalho I; Alves RJ
Bioorg Med Chem Lett; 2014 Sep; 24(18):4529-4532. PubMed ID: 25149510
[TBL] [Abstract][Full Text] [Related]
15. Structural insights into the catalytic mechanism of Trypanosoma cruzi trans-sialidase.
Amaya MF; Watts AG; Damager I; Wehenkel A; Nguyen T; Buschiazzo A; Paris G; Frasch AC; Withers SG; Alzari PM
Structure; 2004 May; 12(5):775-84. PubMed ID: 15130470
[TBL] [Abstract][Full Text] [Related]
16. Lactose derivatives are inhibitors of Trypanosoma cruzi trans-sialidase activity toward conventional substrates in vitro and in vivo.
Agustí R; París G; Ratier L; Frasch AC; de Lederkremer RM
Glycobiology; 2004 Jul; 14(7):659-70. PubMed ID: 15070857
[TBL] [Abstract][Full Text] [Related]
17. Multivalent sialylation of β-thio-glycoclusters by Trypanosoma cruzi trans sialidase and analysis by high performance anion exchange chromatography.
Agustí R; Cano ME; Cagnoni AJ; Kovensky J; de Lederkremer RM; Uhrig ML
Glycoconj J; 2016 Oct; 33(5):809-18. PubMed ID: 27306205
[TBL] [Abstract][Full Text] [Related]
18. Trypanosoma cruzi trans-sialidase. A tool for the synthesis of sialylated oligosaccharides.
Agusti R; Gallo-Rodriguez C; de Lederkremer RM
Carbohydr Res; 2019 Jun; 479():48-58. PubMed ID: 31132642
[TBL] [Abstract][Full Text] [Related]
19. Structural and functional properties of Trypanosoma trans-sialidase.
Schenkman S; Eichinger D; Pereira ME; Nussenzweig V
Annu Rev Microbiol; 1994; 48():499-523. PubMed ID: 7826016
[TBL] [Abstract][Full Text] [Related]
20. Effect of primary structure modifications in Trypanosoma cruzi neuraminidase/trans-sialidase activities.
Cremona ML; Pollevick GD; Frasch AC; Campetella O
Cell Mol Biol (Noisy-le-grand); 1996 Jul; 42(5):697-702. PubMed ID: 8832101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
